ClostraBio

Chicago, IL · Founded 2016 · Privately Held (backing)

Developer of biopharmaceuticals intended to offer therapeutics for food allergies. ClostraBio is based in Chicago, IL and was founded in 2016. It was valued at $16 million at its later-stage round in Sep 2022, the last priced event on record. It has raised $14.2 million across 1 recorded round; the latest was a $9.9 million early-stage round in Sep 2022.

PMV mark · valuation
$16.0M
Oct 2026
Priced at
its later-stage round
Sep 2022
Total raised
$14.2M
Last round
Early Stage VC
Sep 2022
How much has ClostraBio raised?
$14.2Macross 1 recorded rounds · Sep 2022 – Sep 2022

Most recently, ClostraBio raised $9.9M in its Early Stage VC (Sep 2022).

Free account
More of ClostraBio with a free account
  • ·Watch ClostraBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

ClostraBio round by round

1 rounds
Sep 2022Early Stage VC$9.9MSEC filing▮
15 investors participated

How much has ClostraBio raised?

ClostraBio has raised $14.2 million in total; 1 of its rounds is on record. The largest on record was a $9.9 million early-stage round in Sep 2022.

ClostraBio has filed 1 Form D with the SEC, most recently in Sep 2022 ($9.9 million sold to 15 investors).

ClostraBio investors

10 investors are on record for ClostraBio, including Polsky Center for Entrepreneurship and Innovation at the University of Chicago, Mansueto Office, Angela Oakey and Daniel Oakey. The early-stage round in Sep 2022 drew 15 investors.

For fundraisers
Raising for a company like ClostraBio?

10 investors have backed ClostraBio.

See all 10 investors →

Frequently asked about ClostraBio

How much has ClostraBio raised?
ClostraBio has raised $14.2M in total across 1 recorded funding rounds.
When was ClostraBio's last funding round?
ClostraBio's most recent recorded round was Early Stage VC in Sep 2022, raising $9.9M.